A ThermoCool SmartTouch Ablation Catheter (Biosense Webster Inc., Irvine, CA, USA), which is a novel CF-sensing quadripolar ablation catheter with a 3.5-mm external irrigation tip electrode, was used in our study. The ablation catheter was inserted into the right femoral vein and advanced into the right atrium under the guidance of the CARTO 3 electroanatomic mapping system (Biosense Webster Inc.). When the catheter was suspended in the right atrial cavity without endocardial contact, the CF value was calibrated to 0 g (the non-contact baseline value). Then, real-time CF data and the direction of the force vector were shown to the operators. We reconstructed the three-dimensional geometric model of the right atrium and the RVOT under the guidance of the CARTO 3 mapping system in fast anatomical mapping mode.
Thermocool smarttouch ablation catheter
Manufactured by Johnson & Johnson
Sourced in United States
The ThermoCool SmartTouch Ablation Catheter is a medical device used in cardiac procedures. It is designed to deliver controlled radiofrequency energy to targeted areas of the heart to treat certain heart rhythm disorders.
Automatically generated - may contain errors
2 protocols using thermocool smarttouch ablation catheter
1
CF-sensing Catheter Ablation Guidance
2
Comparison of CPAP and PVI Treatments for Sleep Apnea
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
In patients who were randomized to CPAP therapy (AirSense 10 Autoset, ResMed Inc., San Diego, California), we selected the auto set mode for CPAP pressure (between 3 and 15 cm H 2 O) during tolerance testing. Data were downloaded from the CPAP software (RescanÒ, ResMed) to estimate the residual AHI.
Treatment PVI was performed using conscious sedation (midazolam and fentanyl). Five experienced operators performed all the procedures. PVI was achieved with cryoballoon ablation (28-mm Arctic Front Advance cryoballoon catheter and Achieve pulmonary vein catheter; Medtronic Inc.) or radiofrequency (RF) ablation [CARTO 3 (Biosense webster, Diamond Bar, California) system with ThermoCool SmartTouch ablation catheter (Biosense webster) and 12-or 22-polar Lasso pulmonary vein catheter (Johnson & Johnson, New Brunswick, New Jersey)]. Antiarrhythmic drugs were routinely used for 6-8 weeks after PVI. Ablation was considered a failure if antiarrhythmic drugs had to be continued beyond, or reinstituted after, the blanking period.
Treatment PVI was performed using conscious sedation (midazolam and fentanyl). Five experienced operators performed all the procedures. PVI was achieved with cryoballoon ablation (28-mm Arctic Front Advance cryoballoon catheter and Achieve pulmonary vein catheter; Medtronic Inc.) or radiofrequency (RF) ablation [CARTO 3 (Biosense webster, Diamond Bar, California) system with ThermoCool SmartTouch ablation catheter (Biosense webster) and 12-or 22-polar Lasso pulmonary vein catheter (Johnson & Johnson, New Brunswick, New Jersey)]. Antiarrhythmic drugs were routinely used for 6-8 weeks after PVI. Ablation was considered a failure if antiarrhythmic drugs had to be continued beyond, or reinstituted after, the blanking period.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!